Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Tofacitinib treatment for hair loss may worsen acne.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Tofacitinib is an effective and safe treatment for alopecia areata.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Low-intensity ultrasound may help protect hair follicles from chemotherapy-induced hair loss.

Baricitinib is not very effective for severe alopecia areata.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tacalcitol cream effectively and safely treated a rare skin condition called Lichen Spinulosus in two cases.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Deucravacitinib helped a man regrow hair significantly.

Certain cancer drugs can cause skin issues like rashes and itching.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Biological therapy boosts the immune system to effectively fight melanoma.

LGD1069 effectively prevents breast tumors in mice without toxicity.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.